Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Phosphoproteome of CRC organoid

ABSTRACT: Quantitative phosphoproteome of CRC organoid using TMT 11plex

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Ryoji Yao

PROVIDER: PXD052914 | JPOST Repository | Mon Aug 04 00:00:00 BST 2025

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	181024_37A_Phos_TMT_Fr1.raw	Raw
	181024_37A_Phos_TMT_Fr2.raw	Raw
	181024_37A_Phos_TMT_Fr3.raw	Raw
	181024_37A_Phos_TMT_Fr4.raw	Raw
	181024_37A_Phos_TMT_Fr5.raw	Raw

Items per page:

1 - 5 of 17

Similar Datasets

Phosphoproteome

Project description:For phosphoproteome 24 fractions in each TMT set.

2019-12-17 | OEX00001704 | NODE

Phosphoproteome

Project description:Phosphoproteome

2021-10-16 | OEX00011296 | NODE

Phosphoproteome

Project description:Phosphoproteome

2022-04-21 | OEX00016435 | NODE

Global phosphoproteome and transcriptome integration of Chlamydia trachomatis infection

Project description:Gene expression profiles of RNA extracted at 24 or 48h from End1 cells infected with Chlamydia trachomatis or uninfected controls. This experiment forms part of the analysis of phosphoproteome changes after C.trachomatis infection.

2019-01-16 | GSE104166 | GEO

Global phosphoproteome and transcriptome integration of Chlamydia trachomatis infection

Project description:Global phosphoproteome and transcriptome integration of Chlamydia trachomatis infection

| PRJNA411847 | ENA

Quantitative analysis of phosphoproteome in necroptosis reveals a role of TRIM28 phosphorylation in promoting necroptosis-induced cytokine production

Project description:Quantitative analysis of phosphoproteome in necroptosis reveals a role of TRIM28 phosphorylation in promoting necroptosis-induced cytokine production

| PRJNA718774 | ENA

Global phosphoproteome of Leishmania mexicana developmental stages

Project description:Using a combination of phosphoproteome enrichment and tandem mass tag (TMT) labelling-based quantitative proteomic mass spectrometry (MS), we robustly identified and quantified 1,833 phosphorylated proteins across three life cycle stages of Leishmania mexicana (L. mexicana) parasite. Protein kinase domain was the most enriched protein domain in the L. mexicana phosphoproteome. Additionally, this study systematically characterised the perturbing effect of HSP90 inhibition on the global phosphoproteome of the L. mexicana across its life cycle stages and showed that the inhibition causes substantially distinct molecular effects in the promastigotes and the amastigotes. While tanespimycin treatment decreased the phosphorylation of HSP90 and its co-chaperon HSP70 in the amastigotes, the opposite effect was observed in the promastigotes. Additionally, our results show that while kinase activity and microtubule motor activity are highly represented in the negatively affected phosphoproteins of the promastigotes, ribosomal proteins, protein folding, and proton channel activity are preferentially enriched in the perturbed amastigote phosphoproteome. Our results also show that RNA helicase domain was distinctively enriched among the positively affected RNA-binding amastigote phosphoproteome. This study reveals the dramatically different ways the HSP90 inhibition stress modulates the phosphoproteome of the pathogenic amastigotes and provides in-depth insight into the scope of selective molecular targeting in the therapeutically relevant amastigotes.

2023-10-04 | PXD043002 | Pride

RNA Sequencing quantitatively profiles chemical long-term potentiation (LTP) induced gene transcription alteration

Project description:To identify proteins involved in activity dependent synaptic remodeling that are not caused by changes in mRNA levels we performed RNA-seq and TMT-based quantitative MS.

2021-02-20 | GSE110908 | GEO

The Glycogen Synthase Kinase-3 Phosphoproteome: GSK-3 Phosphorylates Multiple Splicing Factors and Regulates Alternative Splicing

Project description:Glycogen Synthase Kinase-3 (GSK-3) is a constitutively active, ubiquitously expressed protein kinase that regulates multiple signaling pathways. Over 100 putative GSK-3 substrates have been reported in diverse cell types based on in vitro kinase assays or genetic and pharmacological manipulation of GSK-3. Many more have been predicted based on a recurrent GSK-3 consensus motif, but this prediction has not been tested by analyzing the GSK-3 phosphoproteome. We used stable isotope labeling of amino acids in culture (SILAC) and mass spectrometry to analyze the repertoire of GSK-3 dependent substrates in mouse embryonic stem cells (ESCs). A comparison of wild-type and Gsk3a;Gsk3b knockout (DKO) ESCs revealed prominent GSK-3-dependent phosphorylation of multiple splicing factors and regulators of RNA biosynthesis, as well as proteins that regulate transcription, translation, and cell division. We demonstrate direct, GSK-3-dependent phosphorylation of the splicing factors RBM8A and PSF as well as the nucleolar protein NPM1. RNA sequencing to compare the transcriptomes of wild-type and Gsk3 DKO ESCs identified more than 210 genes that are alternatively spliced in a GSK-3-dependent manner, supporting a broad role for GSK-3 in regulating alternative splicing. Overall, this study provides the first unbiased analysis of the GSK-3 phosphoproteome and strong evidence for GSK-3 as a regulator of alternative splicing.

2017-08-24 | GSE90921 | GEO

Comprehensive evaluation of RNAlater effect on proteome and phosphoproteome

Project description:Tumors such as pancreatic cancer contain a variety of enzymes including DNases, RNases and proteases which may lead to autolysis of DNA, RNA and proteins during sample processing. In general, RNAlater can be used to keep nucleic acids intact since it contains high concentrations of quaternary ammonium sulfates which denature those enzymes. Although a few studies were carried out to find effect of RNAlater mainly on DNA and RNA, it is largely unknown whether RNAlater affect both proteome and phosphoproteome. Thus, we carried out a systematic and comprehensive analysis of the RNAlater effect on the proteome and phosphoproteome using high-resolution mass spectrometry. Pancreatic tumor tissues from three patients were pulverized using Covaris CP02 Cryoprep device and incubated in RNAlater at 4 °C for 24 hours. We used the 6-plex TMT to measure quantitative information of proteome and phosphoproteome. Peptides fractionated by mid pH reverse phase liquid chromatography were divided into two parts: a portion (~8%) of each mRP fraction was used to profile the global proteome and the rest (~92%) was to survey phosphorylation enriched by IMAC–based approach. As a result, the global profiling identified 186,941 unmodified peptides of 9,152 protein groups, 18,705 phosphopeptides (15,842 phosphosites). When analyzing the unbiased proteomics and phosphoproteomics data, we observed no significant quantitative changes in both proteins and phosphorylation, if any, induced by RNAlater. Therefore, this result confirms that stored tissues in RNAlater do not significantly affect the proteome and phosphoproteome of pancreatic cancer tumors.

2019-05-06 | PXD010710 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data